Apheresis affects bone and mineral metabolism

Bone

Volumn 46, Issue 3, 2010, Pages 789-795

  Amrein, Karin ^a   Katschnig, Claudia ^a   Sipurzynski, Sabine ^a   Stojakovic, Tatjana ^a   Lanzer, Gerhard ^a   Stach, Elisabeth ^a   Pieber, Thomas R ^a   Dobnig, Harald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acid base balance; Blood donation; Bone mineral density; Calcium; Metabolic alkalosis; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CARBOXY TERMINAL TELOPEPTIDE; CITRIC ACID; BIOLOGICAL MARKER; ELECTROLYTE;

ACID BASE BALANCE; ADULT; ALBUMIN BLOOD LEVEL; APHERESIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM INTAKE; CONTROLLED STUDY; FEMALE; FEMUR NECK; HIP; HUMAN; LUMBAR SPINE; MALE; METABOLIC ALKALOSIS; MINERAL METABOLISM; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; THROMBOCYTOPHERESIS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PLASMAPHERESIS;

ACID-BASE EQUILIBRIUM; ADULT; BIOLOGICAL MARKERS; BLOOD DONORS; BONE DENSITY; CROSS-SECTIONAL STUDIES; ELECTROLYTES; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PLASMAPHERESIS; PLATELETPHERESIS;

EID: 77649184198     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.11.008     Document Type: Article

References (21)

1. Bolan C.D., Greer S.E., Cecco S.A., et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001, 41:1165-1171.
2. Laspina S.J., Browne M.A., McSweeney E.N., et al. QTc prolongation in apheresis platelet donors. Transfusion 2002, 42:899-903.
3. Winters J.L. Complications of donor apheresis. J Clinical Apher 2006, 21:132-141.
4. Mendez A., Franziska Wägli F., Schmid I., Frey M. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/L are safe and efficient. Transfus Apher Sci 2007, 36:47-53. 47- 53.
5. Radtke H., Mayer B., Röcker L., et al. Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study. Transfusion 2004, 44:1463-1467.
6. Radtke H., Tegtmeier J., Rocker L., et al. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004, 44:1427-1432.
7. Harrison J.F. Automated red cell collection - quality and value. Transfus Med 2006, 16:155-164.
8. Smith J.W., Gilcher R.O. The future of automated red blood cell collection. Transfus Apher Sci 2006, 34:219-226.
9. Lazarus E.F., Browning J., Norman J., et al. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 2001, 41:756-761.
10. Strauss R.G. Apheresis donor safety - changes in humoral and cellular immunity. J Clin Apher 1984, 2:68-80.
11. Strauss R.G. Effects on donors of repeated leukocyte losses during plateletpheresis. J Clin Apher 1994, 9:130-134.
12. Schulzki T., Seidel K., Storch H., et al. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors. Vox Sang 2006, 91:162-173.
13. Kobayashi I., Hamaoka S., Ozawa H., et al. Hypercoagulable state induced by thrombocytapheresis. J Clin Apher 1993, 8:147-152.
14. Wiltbank T.B., Giordano G.F. The safety profile of automated collections: an analysis of more than 1 million collections. Transfusion 2007, 47:1002-1005.
15. Cimenti C., Sipurzynski S., Gallistl S., et al. Thrombin generation before and after multicomponent blood collection. Transfusion 2008, 48:1584-1590.
16. Tran-Mi B., Storch H., Seidel K., et al. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers. Vox Sang 2004, 86:189-197.
17. Bechtloff S., Tran-My B., Haubelt H., et al. A prospective trial on the safety of long-term intensive plasmapheresis in donors. Vox Sang 2005, 88:189-195.
18. Bolan C.D., Cecco S.A., Yau Y.Y., et al. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects. Transfusion 2003, 43:1414-1422.
19. Koch H.M., Angerer J., Drexler H., et al. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int J Hyg Environ Health 2005, 208:489-498.
20. Buchta C., Bittner C., Heinzl H., et al. Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion 2005, 45:798-802.
21. Buchta C., Bittner C., Hocker P., et al. Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 2003, 43:1115-1120.